A diversified holding corporation investing in healthcare, defence, pharmaceuticals, logistics, and emerging technology — committed to building enterprises that endure.
Smersh Holdings Private Limited is a Bangalore-headquartered holding corporation with a mandate to invest in and develop enterprises across healthcare, pharmaceuticals, defence, logistics, and emerging technology.
Through its principal subsidiary, Waystar RadCorp Private Limited, the Group operates a multi-divisional platform spanning diagnostic radiology, pharmaceutical manufacturing, last-mile logistics, and a venture incubator — each positioned at the intersection of national need and technological advancement.
Smersh Holdings Private Limited · CIN Registered · Bangalore, Karnataka, India
Each division represents a deliberate capital position in sectors defined by structural demand, high barriers to entry, and compounding return profiles.
Advanced radiology services, diagnostic imaging, and tele-reporting infrastructure for hospitals, clinics, and enterprise healthcare systems across India.
Explore Division →Drug-licensed formulation and marketing of prescription and OTC pharmaceutical products, with an emerging nutraceutical pipeline targeting preventive healthcare.
Explore Division →Strategic capital into defence production, national security infrastructure, and dual-use technology platforms with long-duration government-backed return profiles.
Explore Division →End-to-end pharmaceutical and healthcare logistics, cold chain management, and last-mile distribution infrastructure across urban and Tier 2 markets.
Explore Division →Long-horizon capital in essential infrastructure — energy, utilities, agro-processing, and physical asset development with emphasis on sustainable compounding returns.
Explore Division →Early-stage capital, operational infrastructure, and go-to-market support for emerging companies in health technology, life sciences, and industrial automation.
Explore Division →Smersh Holdings operates through Waystar RadCorp Private Limited — its principal operating subsidiary — which houses four vertically integrated business units spanning healthcare, pharmaceuticals, logistics, and technology.
A radiology and diagnostic services platform offering tele-radiology reporting, structured diagnostic services, and hospital-integrated imaging solutions. Operates via a proprietary cloud-based reporting SaaS with multi-hospital connectivity across Karnataka.
A licensed pharmaceutical marketing and distribution entity holding Drug Licenses in Karnataka. Portfolio products include RENVIA (Orlistat 60mg), CALCIVIVE (Calcium Citrate + Micronutrients), and GLYCOPHASE (Metformin + Sitagliptin), with active national distribution.
Healthcare and pharmaceutical logistics platform focused on last-mile delivery, cold chain management, and distribution efficiency. Serves both Group entities and third-party healthcare clients across urban and Tier 2 markets.
An in-house incubation arm that identifies, capitalises, and operationally supports early-stage companies in healthcare technology, nutraceutical innovation, and digital health — leveraging Group infrastructure for accelerated go-to-market.
A domain expert advisory panel providing strategic direction across the financial, investment, and operational functions of the Smersh Holdings Group and its principal subsidiaries with its board of directors.
Founder and principal of Waystar RadCorp Private Limited. Architects Group strategy across healthcare technology, pharmaceutical commercialisation, and venture incubation. Holds MBBS, MD Radiodiagnosis; practises as a Consultant Radiologist while directing cross-portfolio operations and technology development across the Group.
Tenured across prestigious accounting and advisory practices including P Rao & Co. Brings active operational involvement in infrastructure businesses alongside a deep institutional accounting background. Engaged with the Group in a strategic financial advisory and investment advisory capacity — providing CFO-level oversight across corporate structuring, capital allocation, and financial governance.
Waystar Life Sciences has completed onboarding with Tata 1mg, India's leading online pharmacy platform. Flagship nutraceutical product CALCIVIVE (Calcium Citrate + Mg + Zn + VitD3) is now available for pan-India delivery, marking the Group's first national direct-to-consumer distribution milestone.
Read Release →